Akiyama, Mitsuhiro
Takeuchi, Tsutomu
Article History
First Online: 15 March 2018
Compliance with Ethical Standards
:
: No funding was received for the preparation of this article.
: Mitsuhiro Akiyama has received consulting fees, speaking fees, and honoraria from Asahi Kasei Co., Cure Grades Co., and Eisai Co., Ltd, and a research grant from Mitsubishi Tanabe Pharma Co and Keio Medical Association. Tsutomu Takeuchi has received consulting fees, speaking fees and/or honoraria from Pfizer Japan, Mitsubishi Tanabe Pharma, Eisai, Astellas Pharma, and UCB (less than $10,000 each) and Chugai Pharmaceutical, Bristol-Myers K.K., Daiichi Sankyo, AbbVie, Janssen Pharmaceutical K.K., Pfizer Japan, Asahi Kasei Pharma, Takeda Pharmaceutical, AstraZeneca K.K., Eli Lilly Japan K.K., and Novartis Pharma K.K. (more than $10,000 each).